| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |